- Report
- October 2023
- 87 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2022
- 307 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- December 2024
- 339 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- August 2024
- 300 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- April 2022
- 210 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
The Infectious Disease Vaccine market is a subset of the larger Infectious Diseases Drugs market. Vaccines are a form of preventive medicine, designed to protect individuals from contracting a particular infectious disease. Vaccines work by introducing a weakened or inactive form of the virus into the body, which stimulates the immune system to create antibodies that can fight off the virus if it is encountered in the future. Vaccines are typically administered through injection, but some are available in oral or nasal spray form.
The Infectious Disease Vaccine market is highly competitive, with many companies developing and marketing vaccines for a variety of infectious diseases. Companies in the market include Merck, Pfizer, GlaxoSmithKline, Sanofi, Johnson & Johnson, and Novartis. Show Less Read more